Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Appelt

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Proteins|January 1, 1988
Structural comparison of the prokaryotic ribosomal proteins L7/L12 and L30M Leijonmarck, K Appelt, J Badger, et al.
Investigational New Drugs|July 30, 1999
Antitumor efficacy of AG3340 associated with maintenance of minimum effective plasma concentrations and not total daily dose, exposure or peak plasma concentrationsD R Shalinsky, J Brekken, H Zou, et al.
Biochemistry|January 10, 1989
Fluorescence studies of a single tyrosine in a type II DNA binding proteinT Härd, V Hsu, M H Sayre, et al.
Ophthalmic Research|December 15, 2000
The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathyU Ozerdem, B Mach-Hofacre, K Keefe, et al.
The Journal of Biological Chemistry|November 25, 1981
The crystallization of ribosomal proteins from the 50 S subunit of the Escherichia coli and Bacillus stearothermophilus ribosomeK Appelt, J Dijk, R Reinhardt, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2018
<i>In Vitro</i> and <i>In Vivo</i> Activity of a Novel Catheter Lock Solution against Bacterial and Fungal BiofilmsJ Chandra, L Long, N Isham, et al.
American Journal of Respiratory Cell and Molecular Biology|December 1, 2001
Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340)H D Foda, E E Rollo, M Drews, et al.
Journal of Molecular Biology|July 5, 1992
Crystallization and preliminary X-ray crystallographic analysis of Mirabilis antiviral proteinM Miyano, K Appelt, M Arita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studiesD R Shalinsky, J Brekken, H Zou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 27, 2010
Unique requirements for reactivation of virus-specific memory B lymphocytesFlorian J Weisel, Uwe K Appelt, Andrea M Schneider, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Proteins|January 1, 1988
Structural comparison of the prokaryotic ribosomal proteins L7/L12 and L30M Leijonmarck, K Appelt, J Badger, et al.
Investigational New Drugs|July 30, 1999
Antitumor efficacy of AG3340 associated with maintenance of minimum effective plasma concentrations and not total daily dose, exposure or peak plasma concentrationsD R Shalinsky, J Brekken, H Zou, et al.
Biochemistry|January 10, 1989
Fluorescence studies of a single tyrosine in a type II DNA binding proteinT Härd, V Hsu, M H Sayre, et al.
Ophthalmic Research|December 15, 2000
The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathyU Ozerdem, B Mach-Hofacre, K Keefe, et al.
The Journal of Biological Chemistry|November 25, 1981
The crystallization of ribosomal proteins from the 50 S subunit of the Escherichia coli and Bacillus stearothermophilus ribosomeK Appelt, J Dijk, R Reinhardt, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2018
<i>In Vitro</i> and <i>In Vivo</i> Activity of a Novel Catheter Lock Solution against Bacterial and Fungal BiofilmsJ Chandra, L Long, N Isham, et al.
American Journal of Respiratory Cell and Molecular Biology|December 1, 2001
Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340)H D Foda, E E Rollo, M Drews, et al.
Journal of Molecular Biology|July 5, 1992
Crystallization and preliminary X-ray crystallographic analysis of Mirabilis antiviral proteinM Miyano, K Appelt, M Arita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studiesD R Shalinsky, J Brekken, H Zou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 27, 2010
Unique requirements for reactivation of virus-specific memory B lymphocytesFlorian J Weisel, Uwe K Appelt, Andrea M Schneider, et al.
Pageof 6